BioVaxys Technology Corp. (BIOV.CN)
CAD 0.06
(0.0%)
CAD 0.06
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 113.47 Thousand CAD | -86.89% |
| 2022 | 865.56 Thousand CAD | -89.82% |
| 2021 | 8.5 Million CAD | -18.7% |
| 2020 | 10.45 Million CAD | 3315.01% |
| 2019 | 306.26 Thousand CAD | 181.64% |
| 2018 | 108.74 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.47 Million CAD | 1200.76% |
| 2024 Q3 | 2.4 Million CAD | 36.31% |
| 2024 Q2 | 1.76 Million CAD | 19.66% |
| 2023 FY | 113.47 Thousand CAD | -86.89% |
| 2023 Q1 | 1.25 Million CAD | 45.47% |
| 2023 Q2 | 2.65 Million CAD | 110.69% |
| 2023 Q4 | 113.47 Thousand CAD | -91.97% |
| 2023 Q3 | 1.41 Million CAD | -46.75% |
| 2022 Q4 | 865.56 Thousand CAD | -89.02% |
| 2022 FY | 865.56 Thousand CAD | -89.82% |
| 2022 Q3 | 7.88 Million CAD | -1.49% |
| 2022 Q2 | 8 Million CAD | -0.39% |
| 2022 Q1 | 8.03 Million CAD | -5.48% |
| 2021 Q3 | 9.66 Million CAD | 8.02% |
| 2021 Q1 | 8.67 Million CAD | -17.03% |
| 2021 Q2 | 8.94 Million CAD | 3.11% |
| 2021 FY | 8.5 Million CAD | -18.7% |
| 2021 Q4 | 8.5 Million CAD | -12.02% |
| 2020 Q4 | 10.45 Million CAD | 1196.41% |
| 2020 FY | 10.45 Million CAD | 3315.01% |
| 2020 Q3 | 806.76 Thousand CAD | 205.69% |
| 2020 Q2 | 263.91 Thousand CAD | -7.84% |
| 2020 Q1 | 286.35 Thousand CAD | -6.5% |
| 2019 FY | 306.26 Thousand CAD | 181.64% |
| 2019 Q3 | 349.59 Thousand CAD | -10.65% |
| 2019 Q1 | 418.36 Thousand CAD | 0.0% |
| 2019 Q2 | 391.27 Thousand CAD | -6.47% |
| 2019 Q4 | 306.26 Thousand CAD | -12.4% |
| 2018 FY | 108.74 Thousand CAD | 0.0% |
| 2018 Q3 | 89.47 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 4.19 Million CAD | 97.294% |
| Asep Medical Holdings Inc | 25.61 Million CAD | 99.557% |
| BetterLife Pharma Inc. | 324.74 Thousand CAD | 65.056% |
| ChitogenX Inc. | 534 Thousand CAD | 78.749% |
| Rapid Dose Therapeutics Corp. | 1.88 Million CAD | 93.98% |
| Defence Therapeutics Inc. | 477.74 Thousand CAD | 76.247% |
| Entheon Biomedical Corp. | 401.07 Thousand CAD | 71.707% |
| Gemina Laboratories Ltd. | 1.45 Million CAD | 92.208% |
| Glow Lifetech Corp. | 1.91 Million CAD | 94.068% |
| Lexston Life Sciences Corp. | 750.94 Thousand CAD | 84.889% |
| Pharmala Biotech Holdings Inc. | 2.41 Million CAD | 95.296% |
| Doseology Sciences Inc. | 1.1 Million CAD | 89.705% |
| MYND Life Sciences Inc. | 797.54 Thousand CAD | 85.772% |
| Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -265.363% |
| PharmaTher Holdings Ltd. | 2.58 Million CAD | 95.618% |
| PreveCeutical Medical Inc. | 181.51 Thousand CAD | 37.481% |
| Telescope Innovations Corp. | 3.02 Million CAD | 96.247% |